{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:30:51Z","timestamp":1793647851399,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.lanepe.2025.101402","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:35:59Z","timestamp":1755041759000},"page":"101402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain"],"prefix":"10.1016","volume":"56","author":[{"given":"Mariano","family":"Provencio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3402-1144","authenticated-orcid":false,"given":"Manuel","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-1366","authenticated-orcid":false,"given":"Delvys","family":"Rodriguez-Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Carcereny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-4710","authenticated-orcid":false,"given":"Rafael","family":"L\u00f3pez Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fern\u00e1ndez Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyes","family":"Bernab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-7821","authenticated-orcid":false,"given":"Joaquim","family":"Bosch-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartomeu","family":"Massut\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edel","family":"del Barco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0657-4713","authenticated-orcid":false,"given":"Mart\u00edn","family":"L\u00e1zaro-Quintela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00f3mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-0388","authenticated-orcid":false,"given":"Mar\u00eda \u00c1ngeles","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2631-0309","authenticated-orcid":false,"given":"Jos\u00e9 Lu\u00eds","family":"Gonz\u00e1lez-Larriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-1375","authenticated-orcid":false,"given":"Francisco","family":"Aparisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Oramas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9093-4837","authenticated-orcid":false,"given":"Sara","family":"Cerezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-4333","authenticated-orcid":false,"given":"Beatriz","family":"Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-7453","authenticated-orcid":false,"given":"Alberto","family":"Ruano-Ravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-4306","authenticated-orcid":false,"given":"Aylen Vanessa","family":"Ospina-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remei","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Punt\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karmele","family":"Areses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Valdivia Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Sandiego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sequero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Noguer\u00f3n Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Azk\u00e1rate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Mielgo Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Campillo Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Mart\u00ednez Kareaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Majem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gil Bazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Viteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"S\u00e1nchez Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"As\u00fan","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"De Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Catot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mart\u00ed Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lanepe.2025.101402_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101402_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jtho.2021.02.024","article-title":"Tobacco smoking and risk of second primary lung cancer","volume":"16","author":"Aredo","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"19","key":"10.1016\/j.lanepe.2025.101402_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191912201","article-title":"Cancer prevention for survivors: incidence of second primary cancers and sex differences\u2014a population-based study from an Italian cancer registry","volume":"19","author":"Ragusa","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101402_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nrc722","article-title":"Second cancers in survivors of childhood cancer","volume":"2","author":"Bhatia","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101402_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.lanepe.2025.101402_bib6","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lanepe.2025.101402_bib7","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jtho.2021.07.035","article-title":"Brigatinib versus crizotinib in ALK inhibitor\u2013naive advanced ALK-positive NSCLC: final results of phase 3 ALTA-1L trial","volume":"16","author":"Camidge","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.lanepe.2025.101402_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.annonc.2020.04.478","article-title":"Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study","volume":"31","author":"Mok","year":"2020","journal-title":"Ann Oncol"},{"issue":"29","key":"10.1016\/j.lanepe.2025.101402_bib9","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib versus crizotinib in patients with advanced ALK-positive non\u2013small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.lanepe.2025.101402_bib10","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101402_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.22.01503","article-title":"Five-year survival outcomes with nivolumab plus ipilimumab versus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer in CheckMate 227","volume":"41","author":"Brahmer","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101402_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2020.100044","article-title":"Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer","volume":"6","author":"Heudel","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.lanepe.2025.101402_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107280","article-title":"Reduced risk of secondary primary extra pulmonary cancer in advanced\/metastatic lung cancer patients treated with immune checkpoint inhibitors","volume":"182","author":"Heudel","year":"2023","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.lanepe.2025.101402_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28627","article-title":"Assessment of trends in second primary cancers in patients with metastatic melanoma from 2005 to 2016","volume":"3","author":"Deng","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3.5","key":"10.1016\/j.lanepe.2025.101402_bib15","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2024.7144","article-title":"CLO25-063: immune checkpoint inhibitor therapy and the risk of second primary malignancies in melanoma and lung cancer patients","volume":"23","author":"Zyoud","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101402_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11523-016-0459-0","article-title":"Risk of second primary malignancies in lung cancer survivors \u2013 the influence of different treatments","volume":"12","author":"Su","year":"2017","journal-title":"Target Oncol"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101402_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.gaceta.2022.02.013","article-title":"Representativeness of the Spanish Thoracic Tumour Registry. Comparison of sociodemographic data with other national registries","volume":"36","author":"Candal-Pedreira","year":"2022","journal-title":"Gac Sanit"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101402_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.lanepe.2025.101402_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non\u2013small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.lanepe.2025.101402_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.20.03570","article-title":"Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO and OH (CCO) joint guideline update","volume":"39","author":"Hanna","year":"2021","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.lanepe.2025.101402_bib21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.lanepe.2025.101402_bib22","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1200\/JCO.22.01990","article-title":"Pembrolizumab plus chemotherapy in squamous non-small-cell lung cancer: 5-year update of the phase III KEYNOTE-407 study","volume":"41","author":"Novello","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101402_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbres.2023.12.005","article-title":"Comparison of clinical and genetic characteristics between younger and older lung cancer patients","volume":"60","author":"Candal-Pedreira","year":"2024","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101402_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djad039","article-title":"Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer","volume":"115","author":"Bandak","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lanepe.2025.101402_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113355","article-title":"Does perioperative immunotherapy reduce the risk of second primary cancers?","volume":"194","author":"Tagliamento","year":"2023","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.lanepe.2025.101402_bib26","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.annonc.2020.09.001","article-title":"Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer","volume":"31","author":"Heudel","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101402_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2004.06.006","article-title":"Long-term survivors in stage IV non-small cell lung cancer","volume":"47","author":"Okamoto","year":"2005","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101402_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2012.09.015","article-title":"Clinical factors predictive of long-term survival in advanced non-small cell lung cancer","volume":"79","author":"Van Damme","year":"2013","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101402_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1245\/s10434-008-0296-1","article-title":"Lung cancer as a second primary malignancy: increasing prevalence and its influence on survival","volume":"16","author":"Quadrelli","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101402_bib30","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jtcvs.2003.10.039","article-title":"Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies","volume":"127","author":"Brock","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101402_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.1998.507","article-title":"Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation","volume":"783","author":"Kawaharal","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lanepe.2025.101402_bib32","first-page":"1152","article-title":"Second primary tumors involving non-small cell lung cancer\u2217 prevalence and its influence on survival","volume":"127","author":"Duchateau","year":"2005","journal-title":"Chest"},{"issue":"32","key":"10.1016\/j.lanepe.2025.101402_bib33","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/1759-7714.15457","article-title":"Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy","volume":"15","author":"Masui","year":"2024","journal-title":"Thorac Cancer"},{"issue":"5","key":"10.1016\/j.lanepe.2025.101402_bib34","first-page":"469","article-title":"Smoking and lung cancer","volume":"77","author":"Jassem","year":"2009","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.lanepe.2025.101402_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101936","article-title":"Global burden of chronic respiratory diseases and risk factors, 1990\u20132019: an update from the Global Burden of Disease Study 2019","volume":"59","author":"Momtazmanesh","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.lanepe.2025.101402_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107920","article-title":"Family history of cancer and lung cancer: utility of big data and artificial intelligence for exploring the role of genetic risk","volume":"195","author":"Calvo","year":"2024","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101402_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2016.09.002","article-title":"COPD, emphysema and the onset of lung cancer. A systematic review","volume":"382","author":"Mouronte-Roib\u00e1s","year":"2016","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.lanepe.2025.101402_bib38","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.21037\/jtd.2019.10.01","article-title":"Real world data of combined lung cancer and interstitial lung disease","volume":"11","author":"Kawahara","year":"2019","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101402_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12094-015-1342-7","article-title":"Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma","volume":"18","author":"Almagro-Casado","year":"2016","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101402_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.radonc.2014.05.004","article-title":"Risk of second primary lung cancer in women after radiotherapy for breast cancer","volume":"111","author":"Grantzau","year":"2014","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.lanepe.2025.101402_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.43278","article-title":"Second primary lung cancer among lung cancer survivors who never smoked","volume":"6","author":"Choi","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101402_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1470-2045(23)00538-7","article-title":"Cumulative incidence of second primary cancers in a large nationwide cohort of Danish cancer survivors: a population-based retrospective cohort study","volume":"25","author":"Kjaer","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101402_bib43","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225001942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225001942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T22:48:15Z","timestamp":1756421295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776225001942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S2666776225001942"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101402","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101402"}}